To the Editor:
[Regarding your editorial “Autism and the obstetrician” that appeared in the June 2013 issue of Contemporary OB/GYN:]
Is it possible that individually or in combination, prenatal sonography, fetal heart rate Doppler in the office, and fetal monitoring in the labor room are contributing to the cause of autism? This did not occur with such frequency in the age of the fetoscope.
Martin S. Dubner, MD
Suffern, New York
In Reply:
My short answer is: probably not. Abramowicz recently reviewed this topic and concluded that no independently confirmed peer-reviewed published evidence has established a cause-effect relationship between prenatal exposure to clinical ultrasound and subsequent development of autism spectrum disorders (ASDs).1 There is a mouse study suggesting that fairly prolonged (30-minute) exposure to diagnostic ultrasound can affect neuronal migration.2 However, this experimental design is unlikely to be relevant to clinical exposures in humans.
The timing of the sudden surge in ASD diagnoses does overlap with the rise of prenatal ultrasound. However, most observers believe the bulk of the additional diagnoses reflect improved surveillance.
I hope that helps. Thank you for your interest.
Charles J. Lockwood, MD
Editor in Chief, Contemporary OB/GYN
References
1. Abramowicz JS. Ultrasound and autism: association, link, or coincidence?J Ultrasound Med. 2012;31(8):1261-1269.
2. Ang ES Jr, Gluncic V, Duque A, Schafer ME, Rakic P. Prenatal exposure to ultrasound waves impacts neuronal migration in mice.Proc Natl Acad Sci U S A. 2006;103(34):12903-12910.
Hormone therapy safety: Study finds potential benefits for senior women
April 24th 2024A recent large-scale study challenged age-related concerns, suggesting hormone therapy may offer safety and even benefits for menopausal women aged over 65 years, aligning with The Menopause Society's 2022 Position Statement.
Read More
Hyperoxygenation use not linked to neonatal outcomes
April 23rd 2024Recent research evaluated the impact of maternal hyperoxygenation on neonatal Apgar scores, revealing no significant enhancement in outcomes among women with pathologic fetal heart rate tracing and suggesting limited efficacy of hyperoxygenation therapy in this context.
Read More
Study finds antihypertensive treatment reduces uterine fibroids risk
April 23rd 2024A recent study revealed that patients with untreated or new-onset hypertension face elevated chances of uterine fibroid diagnosis, underscoring the potential of antihypertensive therapy in mitigating this risk among midlife individuals.
Read More